Hyris is a company that provides proprietary technology for testing biological samples in any setting, at any time. They offer the first marketplace for genetic testing, enabling access to an open ecosystem. Their solutions cater to healthcare & diagnostics, agrifood & environment, and kit developers.

Hyris is an innovation-based, fast-growing biotech Company, which aims to
democratize genetic analysis by offering
its partners and clients a disruptive System which enables genetic testing of
biological samples in any setting, at any time.
When diagnostic and genetic analysis must be performed under the harshest
conditions, Hyris checks all the boxes.

Pi Campus

Astanor Ventures

Hyris

Hyris supports researchers and developers to launch testing kits via its new Onboarding Programs, leveraging its disruptive AI platform.            
 
Developing and onboarding genetic tests has always been challenging, from staffing and integrating competencies to securing research funding and ensuring sufficient testing volumes; adapting to the various compliance environments, meeting the requirements for molecular assays, and preparing the necessary documentation for market launch can all pose additional risks. 
Technological access gaps remain a major obstacle in the development of new solutions across various industries. Hyris aims to change this by utilizing the advanced AI capabilities of its genetic testing platform, which is well-known for its portability, accessibility, and versatility.

To further speed up the Go-to-market of new tests, Hyris remains committed to its goal of making genetics and health insights accessible to everyone and is taking a new step in its partnership approach. By offering proper education and advanced technical assistance, Hyris’ innovative Onboarding Programs are specifically designed to provide further support to researchers and kit developers at every stage of the process of research and development of diagnostic tests.

Such is the case of Luminis Water Technologies , a leader in microbiome profiling and treatment solutions, which embraced Hyris’ Program to bring on-site qPCR diagnostics to the aquaculture industry, enabling customers to quickly and accurately test for pathogens, viruses, and bacteria, ultimately improving their operations' overall safety and productivity in such industry. Luminis adopted the Hyris system to develop new qPCR diagnostics kits, enabling its customers to perform genetic analysis on-site rather than sending samples to a lab, significantly reducing turnaround time and allowing for more informed decision-making. Additionally, on-site testing eliminates the need for expensive lab equipment, and operators can now perform testing with minimal training.

The new Onboarding Programs are contributing to making Hyris the first choice for testing labs, test developers, and researchers looking to bring on specific tests involving smaller sample arrays, reduced time to results, and increased efficiencies and profitability. 

Hyris keeps true to its vision: to democratize genetics and health insights.

Read the whole article:
https://lnkd.in/dWuvgk9j


Hyris’ unique path brings biotechnologies toward new horizons, combining the potential of a truly connected IoT infrastructure with the Artificial Intelligence embedded into its cloud-software platform, to allow all users new dimensions for the analysis of real-world data and diagnostic trends. 

From Botanicals to Nutraceuticals, from Human Diagnostics to Animal Health, Hyris has been expanding in different industries, providing cutting-edge solutions wherever health is at risk.

Discover more at www.hyris.net
and feel confident to contact an Hyris expert to help you move beyond your current capabilities.

#hyris #hyrissystem #artificialintelligence #iot #innovation 

NET:HYRIS

Hyris

Analysis Not Available